Concepedia

Publication | Open Access

TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects

DOIFull Paper Access

17

Citations

51

References

2020

Year

Jérôme Busserolles, Ismail Ben Soussia, Laetitia Pouchol, Nicolas Marie, Mathieu Méleine, Maïly Devilliers, C. Judon, Julien Schopp, Loïc Clémenceau, Laura Poupon,
British Journal of Pharmacology

Abstract

This proof-of-concept study shows that TREK1 activators could constitute a novel class of painkillers, inspired by the mechanism of action of opioids but devoid of their adverse effects.

References

YearCitations

Page 1